Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical · page 81
- Companies
German and Colombian cannabis markets driving Khiron sales growth
Khiron has expanded its product offerings in both the UK and Germany.
- Medical
Grow group: innovating cannabis medicines and improving access
Grow Group co-founder and CEO Ben Langley spoke about the company’s aims, cannabis innovation and its plans for expansion.
- Pharmaceutical
Oxford Cannabinoid Technologies applies for admission to OTC QB Market
Oxford Cannabinoid Technologies has applied to be admitted to the OTC QB Market in the United States.
- Cultivation
Cannabis genetics to be developed for specific healthcare applications
Swiss Life Sciences says it aims to improve on cannabis medicines that are already being successfully used in treatments with elite genetics.
- Medical
Understanding the future of patient access to medical cannabis
On August 18, along with Torkin Manes LLP, Business of Cannabis presented the online event, “Canadian Cannabis: What’s Next?”
- Medical
Understanding the impact of the election on Canadian cannabis
On August 18, along with Torkin Manes LLP, Business of Cannabis presented the online event, “Canadian Cannabis: What’s Next?”
- Medical
How to understand what’s next for Canadian cannabis
On August 18, along with Torkin Manes LLP, Business of Cannabis presented the online event, “Canadian Cannabis: What’s Next?”
- Medical
Panaxia and Neuraxpharm to bring medical cannabis products to Poland
The exclusive agreement will enable the distribution of Panaxia’s advanced medical cannabis products in Poland.
- Medical
Flowr and Cookies to bring ultra-premium medical cannabis strains to EU
Flowr will be growing some of the most recognisable cannabis strains in the world, including Gelatti and Pink Runtz, in Portugal.
- Medical
Materia enters agreement with Eurox for cannabis extract distribution
Extracts are currently the fastest growing product in the German medical cannabis market.
- Medical
US cannabis medicine technology to be available for European patients
The products will benefit European patients with rapid on-set effects within five to 15 minutes alongside improved absorption efficiency.
- Companies
European cannabis market to reach $4.2bn by 2027
A new report has projected the European medical cannabis market to reach $4.2bn by 2027, growing at a GACR of 17.1% from 2020.
